Company Analysis
Sign in

Medicinova Inc (MNOV)

Nasdaq: MNOV · Pharmaceutical Preparations · La Jolla, CA · filing with the SEC since 2003
Full chart Alerts Compare
Grade5.6
◀ Past 4.8● Present 6.8▶ Future 5.0
2 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

76 patents granted to the 3 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Medicinova Inc’s names, not what it holds today.

Patents granted
76
76 utility, 1976 to Dec 31, 2025
Granted in 2025
2
Against 6 in 2024 and none in 2023
Applications published
92
2 of them in 2025
Names they are printed under
3
its own name, a subsidiary
By yearGrantedApplications published
'11'12'13'14'15'16'17'18'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Pharmaceuticals13
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name3 counted
MediciNova, Inc. its own name
US, as the owner printed on each patent
39 granted
66 published
Avigen, Inc. a subsidiary
US, as the owner printed on each patent
37 granted
25 published
MediciNova, Inc. its own name
named as the applicant on its applications, in US
0 granted
1 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Mar 4, 202512,239,620Methods to decrease triglyceride synthesis in the liverPharmaceuticalsMediciNova, Inc.
Feb 4, 202512,213,966Methods of reducing plasma level of macrophage migratory inhibitory factor in patientsPharmaceuticalsMediciNova, Inc.
Dec 24, 202412,171,752Methods of treating post-COVID condition(s)PharmaceuticalsMediciNova, Inc.
Jul 23, 202412,042,485Methods of minimizing cancer metastasisPharmaceuticalsMediciNova, Inc.
Jun 11, 202412,005,049Methods of preventing cancer metastasisPharmaceuticalsMediciNova, Inc.
Apr 2, 202411,944,607Treatment of progressive neurodegenerative disease with ibudilastPharmaceuticalsMediciNova, Inc.
Mar 12, 202411,925,625Methods of treating chemical gas exposurePharmaceuticalsMediciNova, Inc.
Jan 9, 202411,865,214Ibudilast oral formulations and methods of using samePharmaceuticalsMediciNova, Inc.
Sep 20, 202211,446,283Methods and dosing regimens using ibudilast and a second agent for cancer therapyPharmaceuticalsMediciNova, Inc.
Mar 22, 202211,278,531Combination of ibudilast and riluzole and methods of using samePharmaceuticalsMediciNova, Inc.
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Jul 10, 20252025/0221969METHODS OF REDUCING PLASMA LEVEL OF MACROPHAGE MIGRATORY INHIBITOR FACTOR IN PATIENTSPharmaceuticalsMediciNova, Inc.
Mar 6, 20252025/0073213TREATMENT OF PROGRESSIVE NEURODEGENERATIVE DISEASE WITH IBUDILASTPharmaceuticalsMediciNova, Inc.
Jan 18, 20242024/0016729INJECTABLE FORMULATIONS OF IBUDILASTPharmaceuticalsMediciNova, Inc.
Sep 14, 20232023/0285367METHODS OF TREATING POST-COVID CONDITION(S)PharmaceuticalsMediciNova, Inc. · patent 12,171,752 granted from it
Apr 13, 20232023/0116096METHODS OF MINIMIZING CANCER METASTASISPharmaceuticalsMediciNova, Inc. · patent 12,042,485 granted from it
Mar 23, 20232023/0090534METHODS OF TREATING GLIOBLASTOMA MULTIFORME USING COMBINATION THERAPYPharmaceuticalsMediciNova, Inc.
Feb 2, 20232023/0037014METHODS OF PREVENTING CANCER METASTASISPharmaceuticalsMediciNova, Inc. · patent 12,005,049 granted from it
Dec 8, 20222022/0387364METHODS TO DECREASE TRIGLYCERIDE SYNTHESIS IN THE LIVERPharmaceuticalsMediciNova, Inc. · patent 12,239,620 granted from it
Aug 4, 20222022/0241252METHODS OF TREATING CHEMICAL GAS EXPOSUREPharmaceuticalsMediciNova, Inc. · patent 11,925,625 granted from it
Jun 2, 20222022/0168283TREATMENT OF PROGRESSIVE NEURODEGENERATIVE DISEASE WITH IBUDILASTPharmaceuticalsMediciNova, Inc. · patent 11,944,607 granted from it
What it applied for, 2024 to 2025: Pharmaceuticals 3.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton MNOV · research, not advice